Filing Details

Accession Number:
0001209191-21-018770
Form Type:
4/A
Zero Holdings:
No
Publication Time:
2021-03-08 19:42:33
Reporting Period:
2020-12-23
Accepted Time:
2021-03-08 19:42:33
Original Submission Date:
2020-12-28
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1759425 Mirum Pharmaceuticals Inc. MIRM Pharmaceutical Preparations (2834) 831281555
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1780080 Ian Clements C/O Mirum Pharmaceuticals, Inc.
950 Tower Lane, Suite 1050
Foster City CA 94404
Chief Financial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2020-12-23 1,592 $18.65 7,871 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. This Form 4 is being amended to correct the number of shares purchased and the amount of securities beneficially owned following the reported transaction.